DBPs in drinking water

Recent collaborative work considered THM levels in European drinking waters and the associated burden of bladder cancer. This work also demonstrates the benefit of minimized DBP levels in drinking water.

  • Evlampidou, I., Font-Ribera, L., Rojas-Rueda, D., Gracia-Lavedan, E., Costet, N., Pearce, N., Vineis, P., Jaakkola, J.J.K., Delloye, F., Makris, K.C., Stephanou, E.G., Kargaki, S., Kozisek, F., Sigsgaard, T., Hansen, B., Schullehner, J., Nahkur, R., Galey, C., Zwiener, C., Vargha, M., Righi, E., Aggazzotti, G., Kalnina, G., Grazuleviciene, R., Polanska, K., Gubkova, D., Bitenc, K., Goslan, E.H., Kogevinas, M. and Villanueva, C.M. (2020) Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union. Environmental Health Perspectives 128(1), 017001.

Further publications:

  • Zwiener, C. (2007) Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment. Analytical and Bioanalytical Chemistry 387(4), 1159-1162.   10.1007/s00216-006-0818-2
  • Zwiener, C. and Richardson, S.D. (2005) Analysis of disinfection by-products in drinking water by LC-MS and related MS techniques. Trac-Trends in Analytical Chemistry 24(7), 613-621.   10.1016/j.trac.2005.03.014
  • Zwiener, C. and Kronberg, L. (2001) Determination of the strong mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) and its analogues by GC-ITD-MS-MS. Fresenius Journal of Analytical Chemistry 371(5), 591-597